Palonosetron-A single-dose antiemetic adjunct for hepatic artery radioembolization: A feasibility study

Nasir H. Siddiqi, Atif J. Khan, Phillip M. Devlin

Research output: Contribution to journalArticlepeer-review


Nausea and vomiting may occur in a significant minority of patients following hepatic artery embolization with yttrium-90 spheres (K. T. Sato et al. Radiology 247:507-515, 2008). This encumbers human and economic resources and undercuts the assertion that it is as a well-tolerated outpatient treatment. A single intravenous dose of palonosetron HCl was administered before hepatic artery embolization with yttrium-90 spheres to ameliorate posttreatment nausea and vomiting, in 23 consecutive patients. The patients were discharged the day of procedure on oral antiemetics, steroids, and blockers of gastric acid release. All patients had clinical and laboratory evaluation at 2 weeks after the procedure. The data were gathered and reviewed retrospectively. At 2-week follow-up, none reported significant nausea, vomiting, additional antiemetic use, need for parenteral therapy, hospital readmission, or palonosetron-related side effects. All patients recovered from postembolization symptoms within a week after treatment. In conclusion, this retrospective study suggests that single-dose palonosetron is feasible, safe, and effective for acute and delayed nausea and vomiting in this group of patients. The added cost may be offset by benefits.

Original languageEnglish (US)
Pages (from-to)47-51
Number of pages5
JournalCardiovascular and Interventional Radiology
Issue number1
StatePublished - Jan 2009

All Science Journal Classification (ASJC) codes

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine


  • Palonosetron
  • Postembolization syndrome (PES)
  • Radioembolization (RE)
  • Selective internal radiation therapy (SIRT)
  • Yttrium-90 spheres


Dive into the research topics of 'Palonosetron-A single-dose antiemetic adjunct for hepatic artery radioembolization: A feasibility study'. Together they form a unique fingerprint.

Cite this